Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

Open Menu



Graduate school BSRT receives 2nd funding period

Back to Overview

You are here:

BSRT receives funding from the Excellence Initiative for a further five years.

The Berlin-Brandenburg School for Regenerative Therapies is being funded under the Excellence Initiative for a further five years until 2017. The graduate school, which is a joint initiative of clinicians, natural, material and engineering sciences, develops new therapies in the field of regenerative medicine.

With the funding of the BSRT in the second round of the DFG Excellence Initiative, the Graduate School intends to further expand its programme. Postdocs can realise their own innovative scientific ideas in regenerative medicine with the support of the BSRT network. Master's students of science courses at Berlin's universities gain their first insights into research at the BSRT. A special training from clinicians to scientists (Clinical Scientist) is further developed into a Charité wide model. The central goal is the interdisciplinary cooperation of the various young scientists in the field of regenerative medicine - from the basics to applications. Innovative training concepts are used, which were developed as a "BioThinking" program by the graduate school. In addition to Freie Universität Berlin, Humboldt-Universität zu Berlin, and Technische Universität Berlin, Max Planck, Helmholtz, Fraunhofer, and Leibniz Institutes as well as the Hasso Plattner Institute are involved.  

Since 2007, the graduate school offers doctoral students from the fields of medicine, natural sciences, materials science and engineering the opportunity to conduct top-level research in the field of regenerative medicine. The scientists pursue the goal of regenerating and healing tissues and organs that are affected by aging processes, diseases, traumas or congenital anomalies. By closely interlinking basic research and clinical application, the research findings gained can be rapidly translated into new therapies.


Back to Overview